Why the study?
Do echocardiographic parameters of right ventricular function predict clinical deterioration in patients with pulmonary hypertension receiving specific vasodilator therapy?
Do echocardiographic parameters of right ventricular function predict clinical deterioration in patients with pulmonary hypertension receiving specific vasodilator therapy?
Baseline right ventricular fractional area change independently predicts clinical deterioration in patients with pulmonary hypertension treated with specific vasodilator therapy.
No takes yet. Share an insight, caveat, or question.
May inform risk stratification in treated PH; leaves open prospective validation before guiding therapy.
Giuşcă et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: